Cefepime

Description

1. Product Overview

Cefepime is a fourth-generation cephalosporin antibiotic widely utilized in pharmaceutical manufacturing for the formulation of broad-spectrum antibacterial therapies. It is highly effective against both Gram-positive and Gram-negative bacteria, making it a critical active pharmaceutical ingredient (API) in hospital-grade injectable antibiotics. The key value proposition lies in its high efficacy, stability, and established clinical reliability, supporting advanced infection control protocols. Strategically, Cefepime remains an essential API in global healthcare systems, driven by increasing antimicrobial resistance and demand for potent, broad-spectrum antibiotics.

2. Key Specifications & Technical Characteristics

• Chemical Composition:
  • Cefepime Hydrochloride (C₁₉H₂₄N₆O₅S₂·HCl·H₂O)
  • Beta-lactam cephalosporin structure
• Purity Level / Grade:
  • Pharmaceutical grade (USP/EP/BP compliant)
  • Typical purity: ≥98.5%
  • Endotoxin and sterility levels compliant with pharmacopeial standards
• Physical Characteristics:
  • Form: Sterile powder or crystalline powder
  • Color: White to off-white
  • Solubility: Highly soluble in water
  • pH (solution): Typically 4.0–6.0
  • Particle size: Controlled for injectable formulation
• Packaging Options:
  • Sterile, double-lined pharmaceutical-grade bags
  • Fiber drums (10–25 kg)
  • Custom sterile packaging for bulk API supply
• Shelf Life:
  • Typically 24–36 months under controlled storage conditions
  • Store in cool, dry, light-protected environment

3. Core Industrial Applications

Primary Industries:

• Pharmaceutical manufacturing
• Biotechnology companies
• Contract manufacturing organizations (CMOs)
• Hospital and clinical supply chains

Operational Use Cases:

• Formulation of injectable antibiotics for severe bacterial infections
• Production of hospital-grade anti-infective drugs
• API input for combination antibiotic therapies
• Clinical and regulated pharmaceutical production pipelines

Performance & Cost Advantages:
Cefepime offers superior broad-spectrum antibacterial activity compared to earlier-generation cephalosporins, reducing the need for multiple antibiotic combinations. Its stability and efficacy improve treatment outcomes and streamline formulation processes. For pharmaceutical manufacturers, it provides a high-value API with strong global demand and established regulatory acceptance.

4. Competitive Advantages

• Quality Consistency: Manufactured under GMP-compliant facilities with strict batch-to-batch uniformity
• Supply Reliability: Scalable production capacity ensuring continuous API availability
• Logistics Capability: Global cold-chain and compliant pharmaceutical transport systems
• Price Competitiveness: Optimized production efficiencies for competitive bulk API pricing
• Sustainability Benefits: Efficient synthesis processes with controlled waste management systems
• Technical Documentation: Full regulatory support including DMF, COA, SDS, and validation documentation

Positioned as a strategic sourcing decision, Cefepime enables pharmaceutical buyers to secure a critical, high-demand antibiotic API with consistent quality, regulatory compliance, and dependable global supply.

5. Commercial & Supply Information

• Minimum Order Quantity (MOQ): BULK 20MT
• Loading Capacity (MT per container): Approximately 10–15 MT per 20’ container (subject to packaging, sterility requirements, and regulatory constraints)